BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 8721615)

  • 1. The role of oxidized lipoproteins in atherogenesis.
    Berliner JA; Heinecke JW
    Free Radic Biol Med; 1996; 20(5):707-27. PubMed ID: 8721615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized low-density lipoprotein and atherosclerosis.
    Devaraj S; Jialal I
    Int J Clin Lab Res; 1996; 26(3):178-84. PubMed ID: 8905449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs.
    Hajjar DP; Haberland ME
    J Biol Chem; 1997 Sep; 272(37):22975-8. PubMed ID: 9287290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis.
    Holvoet P; Collen D
    Atherosclerosis; 1998 Apr; 137 Suppl():S33-8. PubMed ID: 9694539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis.
    Thomas SR; Stocker R
    Free Radic Biol Med; 2000 Jun; 28(12):1795-805. PubMed ID: 10946221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives.
    Rubbo H; Parthasarathy S; Barnes S; Kirk M; Kalyanaraman B; Freeman BA
    Arch Biochem Biophys; 1995 Dec; 324(1):15-25. PubMed ID: 7503550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidatively modified LDL and atherosclerosis: an evolving plausible scenario.
    Jialal I; Fuller CJ
    Crit Rev Food Sci Nutr; 1996 Apr; 36(4):341-55. PubMed ID: 8740438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis.
    Cox DA; Cohen ML
    Pharmacol Rev; 1996 Mar; 48(1):3-19. PubMed ID: 8685247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized low density lipoproteins in atherogenesis: role of dietary modification.
    Reaven PD; Witztum JL
    Annu Rev Nutr; 1996; 16():51-71. PubMed ID: 8839919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement.
    Upston JM; Terentis AC; Stocker R
    FASEB J; 1999 Jun; 13(9):977-94. PubMed ID: 10336881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation.
    Mackness MI; Abbott C; Arrol S; Durrington PN
    Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):829-34. PubMed ID: 8379937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis.
    Ylä-Herttuala S
    Ann Med; 1991; 23(5):561-7. PubMed ID: 1721825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis.
    Heinecke JW
    Curr Opin Lipidol; 1997 Oct; 8(5):268-74. PubMed ID: 9335950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The significance of ixidized low density lipoprotein in atherosclerosis].
    Hansen PR
    Ugeskr Laeger; 1996 May; 158(19):2706-10. PubMed ID: 8744072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative hypothesis of atherogenesis.
    Klatt P; Esterbauer H
    J Cardiovasc Risk; 1996 Aug; 3(4):346-51. PubMed ID: 8946263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E and atherosclerosis: beyond prevention of LDL oxidation.
    Meydani M
    J Nutr; 2001 Feb; 131(2):366S-8S. PubMed ID: 11160562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1).
    Matthews AJ; Vercellotti GM; Menchaca HJ; Bloch PH; Michalek VN; Marker PH; Murar J; Buchwald H
    J Surg Res; 1997 Nov; 73(1):35-40. PubMed ID: 9441790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis.
    Parthasarathy S; Steinberg D; Witztum JL
    Annu Rev Med; 1992; 43():219-25. PubMed ID: 1580586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress.
    Heinecke JW
    Free Radic Biol Med; 2002 Jun; 32(11):1090-101. PubMed ID: 12031894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.